Metabolic Research

What Comes After R3TA?

The follow-up questions research still needs to answer about durability, rebound, body composition, and metabolic endpoints.

The phrase “what comes after R3TA?” can sound like a request for the next compound in a sequence. The better scientific question is what researchers should measure after an R3TA study reaches its primary endpoint. A final body-weight value cannot show what persists, what reverses, or which tissues and metabolic systems change during follow-up.

As of September 27, 2026, retatrutide has generated positive phase 3 topline results across several TRIUMPH studies, but the dedicated TRIUMPH-6 maintenance study has not yet reported results. That leaves the post-intervention period as one of the most important remaining evidence gaps.

Positive efficacy results and maintenance evidence are not interchangeable. Efficacy trials ask how outcomes differ during a defined intervention. Maintenance and withdrawal designs ask what happens after a response has already been established. They need different baselines, comparisons, timelines, and interpretations.